Correlation Between Gilead Sciences and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Ikena Oncology, you can compare the effects of market volatilities on Gilead Sciences and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Ikena Oncology.
Diversification Opportunities for Gilead Sciences and Ikena Oncology
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Gilead and Ikena is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Ikena Oncology go up and down completely randomly.
Pair Corralation between Gilead Sciences and Ikena Oncology
Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.35 times more return on investment than Ikena Oncology. However, Gilead Sciences is 1.35 times more volatile than Ikena Oncology. It trades about 0.09 of its potential returns per unit of risk. Ikena Oncology is currently generating about 0.03 per unit of risk. If you would invest 8,951 in Gilead Sciences on September 2, 2024 and sell it today you would earn a total of 307.00 from holding Gilead Sciences or generate 3.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Ikena Oncology
Performance |
| Timeline |
| Gilead Sciences |
| Ikena Oncology |
Gilead Sciences and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Ikena Oncology
The main advantage of trading using opposite Gilead Sciences and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |